Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6456132 | 1.00 | ALDH1A1 (0.48) | ALDH1A1NPSR1PAX8CTDSP1 | |
| SCHEMBL1966547 | 1.00 | ALDH1A1 (0.48) | ALDH1A1NPSR1PAX8CTDSP1 | |
| SCHEMBL11774123 | 1.00 | ALDH1A1 (0.48) | ALDH1A1NPSR1PAX8CTDSP1 | |
| SCHEMBL11773747 | 1.00 | ALDH1A1 (0.48) | ALDH1A1NPSR1PAX8CTDSP1 | |
| SCHEMBL1964310 | 0.97 | — | — | |
| SCHEMBL11772816 | 0.92 | — | — | |
| SCHEMBL11773472 | 0.85 | — | — | |
| SCHEMBL949427 | 0.82 | ALDH1A1 (0.58) | ALDH1A1NPSR1PAX8CTDSP1 | |
| SCHEMBL947101 | 0.78 | ALDH1A1 (0.53) | ALDH1A1NPSR1PAX8CTDSP1 | |
| SCHEMBL6740183 | 0.77 | ALDH1A1 (0.52) | ALDH1A1NPSR1PAX8CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1362023-B1 | METHOD FOR PRODUCING MACROCYCLIC KETONES | GIVAUDAN SA (CH) | 2009-04-15 | — | — | EP | claimed |
| US-6951964-B2 | Method for producing macrocyclic ketones | GIVAUDAN SA (CH) | 2005-10-04 | — | — | US | claimed |
| US-20040082816-A1 | Method for producting macrocyclic ketones | GIVAUDAN SA (CH) | 2004-04-29 | — | — | US | claimed |
| US-6951964-B2 | Method for producing macrocyclic ketones | GIVAUDAN SA (CH) | 2005-10-04 | — | — | US | disclosed |
| US-20040082816-A1 | Method for producting macrocyclic ketones | GIVAUDAN SA (CH) | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082816-A1 | Method for producting macrocyclic ketones | ADH1C, ADH1A, AKR1C3 | ALDH1A1 71/4885NPSR1 2908/4885PAX8 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.